Fundraising Fox

Inventure

Southbury, US · Delaware LLC · 8 known investors

Biotech

Founders & leadership

KS
Kyle SalemExecutive
BD
Bill DoyleExecutive
JB
Jonathan BalfourExecutive
RR
Richard RoseneExecutive

Board

BR
Brad RummerBoard director
RD
Richard DeslauriersBoard director

Investors · 8

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 11 rounds · 2015–2026

$200KraisedFeb 2026 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard DeslauriersDirector
Offering amount
$200K
Amount sold
$200K
Minimum investment
$50K
First sale
Feb 2026
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$361.5KraisedJul 2025 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kyle SalemExecutive Officer
  • Brad RummerDirector
  • Richard DeslauriersDirector
Offering amount
$361.5K
Amount sold
$361.5K
Minimum investment
$10K
First sale
Jul 2025
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedAug 2023 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J DeslauriersDirector
Offering amount
$250K
Amount sold
$250K
Minimum investment
$25K
First sale
Jul 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.1MraisedMar 2023 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J DeslauriersDirector
Offering amount
$2.1M
Amount sold
$2.1M
Minimum investment
$25K
First sale
Aug 2021
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedSep 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J DeslauriersDirector
Offering amount
$1M
Amount sold
$1M
Minimum investment
$1M
First sale
Sep 2021
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$45KraisedJan 2021 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J DeslauriersDirector
  • Brad RummerDirector
Offering amount
$45K
Amount sold
$45K
Minimum investment
$45K
First sale
Dec 2020
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$350KraisedMar 2020 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert F. JacobsExecutive Officer
  • Richard J. DeslauriersDirector
  • Brad RummerDirector
Offering amount
$500K
Amount sold
$350K
Minimum investment
$50K
First sale
Dec 2019
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$175KraisedOct 2019 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert F. JacobsExecutive Officer
  • Richard J. DeslauriersDirector
  • Brad RummerDirector
Offering amount
$250K
Amount sold
$175K
Minimum investment
$25K
First sale
Oct 2019
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Inventure's investors?
Inventure's investors include Balderton Capital, CDP Venture Capital, FELIX CAPITAL, Metaplanet, Passion Capital, Stena Sessan, Superhero Capital, Union Square Ventures (USV).
How much funding has Inventure raised?
Inventure has disclosed $6M raised across 11 rounds.
Where is Inventure headquartered?
Inventure is headquartered in Southbury, US.